16 results on '"total body protein"'
Search Results
2. The usefulness of total body protein mass models for adolescent athletes
- Author
-
Analiza M. Silva, Francesco Campa, and Luís B. Sardinha
- Subjects
body composition ,adolescent athletes ,total body protein ,DXA ,multicomponent models ,Nutrition. Foods and food supply ,TX341-641 - Abstract
The present study aimed to assess the utility of a less laborious technique for estimating total body protein (TBPro) in young athletes, using a multicomponent model as the criterion method. A total of 88 (49 boys and 39 girls) adolescent athletes (age: 15.2 ± 1.5 years; body mass index: 21.2 ± 2.7 kg/m2) participated. A 6-compartment model was used as the reference method (TBProReference) involving air displacement plethysmography for body volume, dual-energy X-ray absorptiometry (DXA) for bone mineral content, and deuterium dilution for total body water (TBW). Alternatively, DXA TBPro models were used as TBPro = lean-soft mass (LSM) − HFFFM × fat-free mass (FFM) − Ms. − G, where LSM and FFM were assessed using DXA, HFFFM is the hydration fraction of the FFM using measured TBW or assumed TBW (adult fraction of 0.732; Lohman’s constants or mean observed HFFFM), Ms. is soft tissue minerals (Ms = 0.0129 × HFFFM × FFM), and G is glycogen calculated as 0.044 × (LSM − HFFFM × FFM − Ms). The maturation level was determined by self-assessment. TBPro obtained from DXA using the assumed HFFFM explained 73% to 77% of the variance compared to TBProReference. Meanwhile, using the mean values of measured HFFFM, the DXA model explained 53 and 36% for boys and girls, respectively. Larger bias (8.6% for boys and 25.8% for girls) and limits of agreement were found for the DXA model using measured HFFFM (boys for 66.9% and girls for 70%) compared to an assumed HFFFM (bias ranged from 1.5% to 22.5% and limits of agreement ranged from 31.3% to 35.3%). Less complex and demanding TBPro DXA models with the assumed HFFFM are valid alternatives for assessing this relevant FFM component in groups of adolescent athletes but are less accurate for individual results. Though future studies should be conducted to test the usefulness of these models in longitudinal and experimental designs, their potential to provide an estimation of protein mass after exercise and diet interventions in young athletes is anticipated.
- Published
- 2024
- Full Text
- View/download PDF
3. Insecticidal Activity of Tannins from Selected Brown Macroalgae against the Cotton Leafhopper Amrasca devastans.
- Author
-
Petchidurai, Ganeshan, Sahayaraj, Kitherian, Al-Shuraym, Laila A., Albogami, Bader Z., and Sayed, Samy M.
- Subjects
TANNINS ,GALLIC acid ,LEAFHOPPERS ,MARINE algae ,SUPERPHOSPHATES ,DIGESTIVE enzymes ,LIPASES - Abstract
Seaweeds, also known as marine macroalgae, are renewable biological resources that are found worldwide and possess a wide variety of secondary metabolites, including tannins. Drifted brown seaweed (DBSW) is particularly rich in tannins and is regarded as biological trash. The cotton leaf hopper Amrasca devastans (Distant) has caused both quantitative and qualitative losses in cotton production. Drifted brown seaweeds (DBSWs) were used in this study to extract, qualitatively profile, and quantify the levels of total tannins, condensed tannins, hydrolyzable tannins, and phlorotannins in the seaweeds; test their insecticidal activity; and determine the mechanism of action. The largest amount of tannin extract was found in Sargassum wightii Greville (20.62%) using the Soxhlet method (SM). Significantly higher amounts of hydrolyzable tannins (p = 0.005), soluble phlorotannins (p = 0.005), total tannins in the SM (p = 0.003), and total tannins in the cold percolation method (p = 0.005) were recorded in S. wightii. However, high levels of condensed tannins (CTAs) were observed in Turbinaria ornata (Turner) J. Agardh (p = 0.004). A. devastans nymphs and adults were examined for oral toxicity (OT) and contact toxicity (CT) against DBSW tannin crude extract and column chromatographic fractions 1 (Rf = 0.86) and 2 (Rf = 0.88). Stoechospermum polypodioides (J.V. Lamouroux) J. Agardh crude tannin was highly effective against A. devastans using the OT method (LC
50 , 0.044%) when compared with the standard gallic acid (LC50 , 0.044%) and tannic acid (LC50, 0.122%). Similarly, S. wightii fraction 2 (LC50 , 0.007%) showed a greater insecticidal effect against A. devastans adults in OT than gallic acid (LC50 , 0.034%) and tannic acid (LC50 , 0.022%). The mechanism of action results show that A. devastans adults treated with crude tannin of T. ornata had significantly decreased amylase, protease (p = 0.005), and invertase (p = 0.003) levels when compared with the detoxification enzymes. The levels of glycosidase, lactate dehydrogenase, esterase, lipase, invertase, and acid phosphate activities (p = 0.005) of S. wightii were reduced when compared with those of the Vijayneem and chemical pesticide Monocrotophos. In adult insects treated with LC50 concentrations of S. wightii tannin fraction 1, the total body protein (9.00 µg/µL) was significantly reduced (OT, LC50 —0.019%). The SDS-PAGE analysis results also show that S. wightii tannin fraction 1 (OT and CT), fraction 2 (OT), and S. polypodioides fraction 2 (CT) had a significant effect on the total body portion level, appearance, and disappearance of some proteins and polypeptides. This study shows that the selected brown macroalgae can be utilized for the safer management of cotton leaf hoppers. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
4. Incomplete total body protein recovery in adolescent patients with anorexia nervosa.
- Author
-
Haas, Verena, Kent, Dorothea, Kohn, Michael R, Madden, Sloane, Clarke, Simon, Briody, Julie, Fischer, Felix, Müller, Manfred J, and Gaskin, Kevin
- Subjects
ANOREXIA nervosa ,EXERCISE ,LONGITUDINAL method ,SCIENTIFIC observation ,PROTEIN deficiency ,WEIGHT gain ,BODY mass index ,RECEIVER operating characteristic curves ,DESCRIPTIVE statistics ,NUTRITIONAL status ,PHOTON absorptiometry ,ADOLESCENCE - Abstract
Background: Bone health and growth during adolescence require adequate total body protein (TBPr). Renutrition for patients with anorexia nervosa (AN) should aim to normalize body composition and to recover both fat mass and TBPr. Objective: We intended to analyze predictors of protein status, including exercise status, in adolescents with AN and to investigate whether weight gain would replenish body protein deficits. Methods: We assessed TBPr in a longitudinal, observational study as height-adjusted nitrogen index (NI) using in vivo neutron activation analysis in 103 adolescents with AN [mean ± SD age, 15.6 ± 1.4 y; body mass index (BMI, in kg/m²), 16.5 ± 1.6] at the commencement of inpatient refeeding (T0), in 56 of these patients 7 mo thereafter as outpatients (T1), and in age-matched controls (C; n = 51, 15.5 ± 2.1 y, BMI 20.7 ± 1.9). Lean tissue and fat mass were assessed by dualenergy X-ray absorptiometry. BMI, BMI standard deviation score, and lean tissue mass were tested as predictors of protein status using receiver operating characteristic analysis. Results: At T0, NI was decreased in AN (AN, 0.88 ± 0.10 compared with C, 1.00 ± 0.08, P < 0.001). In 34%, the patients showed protein depletion. Patients classified as "exercisers" had a higher NI than did "nonexercisers" (0.89 ± 0.11 compared with 0.85 ± 0.08, P = 0.045). BMI, BMI standard deviation score, and lean tissue mass did not show potential as predictors of protein status. Despite increases in weight (+6.9 ± 4.5 kg), and BMI (+2.5 ± 1.7), protein status did not improve (TBPr T0, 8.0 ± 1.1 kg; T1, 8.1 ± 1.0 kg, P = 0.495). In an AN subgroup at 7 mo matched with controls in age (AN, 16.5 ± 1.1 y; C, 16.2 ± 1.8 y) and BMI (AN, 20.5 ± 1.4; C, 20.7 ± 1.3), protein status was still not normalized in AN (NI: AN, 0.89 ± 0.09 compared with C, 1.00 ± 0.07, P < 0.001). Conclusions: Adolescents recovering from AN remained protein depleted at 7 mo after baseline assessment, even though they were weight restored. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
5. Infection, Bacteremia, Sepsis, and the Sepsis Syndrome: Metabolic Alterations, Hypermetabolism, and Cellular Alterations
- Author
-
Majetschak, Matthias, Waydhas, Christian, Baue, Arthur E., editor, Faist, Eugen, editor, and Fry, Donald E., editor
- Published
- 2000
- Full Text
- View/download PDF
6. Comparing the Response of the Brown Shrimp Crangon crangon (Linnaeus, 1758) to Prolonged Deprivation of Food in Two Seasons.
- Author
-
Moreira, Cláudia Filipa Devesa Andr, Carvalho, António Paulo Alves Ferreira De, and Campos, Joana Costa Vilhena De Bessa
- Abstract
Crustaceans often undergo periods of starvation, due to natural food shortage or physiological constraints. During these periods, several metabolic and behavioral changes can occur. This study evaluates how the brown shrimp Crangon crangon (Linnaeus, 1758) responds to prolonged deprivation of food in two seasons of the year, and how this species mobilizes its energetic reserves. Shrimps caught in June (summer) and October (autumn) 2010 in the Minho estuary (north of Portugal) were placed in individual cages in experimental aquaria and kept in starvation until the last shrimp died or was sacrificed (six shrimp per aquarium every week). The energetic content, total lipids and total protein, and the oxygen consumption rate were compared between seasons, sacrificed and naturally dead shrimp, and considering the weeks of starvation. Summer shrimp proved to be better prepared to endure starvation than those caught in autumn: they survived 2.5 times longer, had a higher Fulton condition factor, higher energy, and higher lipid and protein content at the beginning of the experiments. The percentage of total body protein decreased significantly in the first week, stabilized in the following to decrease again abruptly in the fifth week. The percentage of total lipids only started to decrease after four weeks. This suggests that (1) C. crangon probably uses protein as a first energetic resource, followed by carbohydrates and eventually lipids, though to a much lesser extent; and (2) after 4 wk of starvation, a critical point is reached when structural components may be mobilized to satisfy maintenance costs. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
7. Oral β-blockade in relation to energy expenditure in clinically stable patients with liver cirrhosis: A double-blind randomized cross-over trial.
- Author
-
Lee, Wai Gin, McCall, John L., Gane, Edward J., Murphy, Rinki, and Plank, Lindsay D.
- Subjects
CALORIC expenditure ,CIRRHOSIS of the liver ,ADRENERGIC beta blockers ,LIVER transplantation ,C-reactive protein ,CHRONIC kidney failure ,RANDOMIZED controlled trials - Abstract
Abstract: Elevated resting energy expenditure (REE) is seen in liver cirrhosis and is associated with reduced transplant-free survival. Non-selective β-blockers reduce REE in acute hypermetabolic conditions. We examined whether non-selective β-blockers reduce REE in patients with stable liver cirrhosis. Twenty-two stable cirrhotic patients (Child–Pugh grading: 19A, 2B, 1C) were randomized to 3-month treatment with nadolol (titrated to decrease resting pulse rate by 20%) or placebo and after a 1-month washout period crossed to the alternative treatment for a further 3months. REE was measured by indirect calorimetry and total body protein by neutron activation analysis at the beginning and end of each 3-month period of treatment. A predicted REE was calculated for each patient based on total body protein. A measured to predicted REE ratio >1.22 indicated significantly elevated REE. The primary outcome was REE at the end of 3-month treatment with nadolol compared with placebo. Elevated REE was seen in one patient at study entry. After 3months on placebo REE was 1506±40 (SEM) kcal/d and on nadolol, 1476±40kcal/d, a mean reduction of 31±16kcal/d (P= .076). Total body protein changes were not significant. Nadolol was well tolerated with no increase in the rate of adverse events. In stable cirrhotic patients, nadolol was not associated with reduction in REE. A larger, longer-term study with different eligibility criteria is required to investigate whether this treatment offers benefits additional to its use for prevention of variceal hemorrhage. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
8. Changes in body composition, muscle function and energy expenditure after radical cystectomy.
- Author
-
Mathur, Sachin, Plank, Lindsay D., Hill, Andrew G., Rice, Michael A., and Hill, Graham L.
- Subjects
- *
SURGERY , *HUMAN body composition , *CALORIC expenditure , *PROTEINS , *NUCLEAR activation analysis , *MUSCLE strength - Abstract
OBJECTIVE To determine the changes in body composition, muscle function and energy expenditure after radical cystectomy (RC). PATIENTS AND METHODS Eleven consecutive men (median age 66 years, range 44–79) who had a RC over a 1-year period had measurements made of their total body protein, by neutron-activation analysis, total body water by tritium dilution, total body potassium by whole-body counting, resting energy expenditure by indirect calorimetry, and grip strength and respiratory muscle strength. These variables were measured on the day before surgery and at 2 weeks and 6 months after RC. Total body fat was derived using a multicompartment model. Artificial nutritional support was not provided after RC and no oral caloric intake was provided until bowel function returned. RESULTS Five patients were malnourished before RC and four had significant complications afterward. Over the first 2 weeks there were significant losses in mean (sem) protein levels, at 0.68 (0.17) kg ( P < 0.001) and water, at 3.00 (0.73) L ( P < 0.001), while body fat was unchanged. Resting energy expenditure was 11% higher than predicted at 14 days after RC ( P < 0.001). Body potassium changes mirrored the protein changes but were not statistically significant. Over the subsequent 6 months, 63%, i.e. 0.43 (0.24) kg, of the body protein lost after surgery was regained. Muscle function had returned to baseline levels at 6 months. CONCLUSIONS This study shows that the catabolic loss of body protein after RC is not regained by 6 months. Regimens directed at early nutritional support after RC for these patients might improve the recovery of body composition, with consequent clinical benefits. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
9. Body composition of children with chronic and end-stage renal failure.
- Author
-
Nydegger, Andreas, Strauss, Boyd J. G., Heine, Ralf G., Asmaningsih, Ninik, Jones, Colin L., and Bines, Julie E.
- Subjects
- *
MALNUTRITION in children , *CHRONIC kidney failure in children , *GLOMERULAR filtration rate , *PROTEIN content of food , *ANTHROPOMETRY - Abstract
Aim: Protein energy malnutrition is common in children with chronic renal failure (CRF) and may negatively impact on clinical outcome. Although the aetiology of malnutrition is multifactorial, descriptive information on body composition may guide nutritional interventions aimed at optimising nutritional status. Methods: This prospective cohort study in children with CRF was conducted from April 1999 to November 2000. Patients were categorised according to their glomerular filtration rate (GFR) into CRF and end-stage renal failure (ESRF). Body composition was assessed based on anthropometry, total body potassium (TBK), total body protein (TBP) and dual X-ray absorptiometry (DEXA). Results: Fifteen patients (10 male, 5 female; mean age: 13.4 ± 4.3 years) were studied, including eight patients with CRF (mean GFR: 17.0 ± 7.2 mL/min/1.73 m2) and seven patients with ESRF (mean GFR: 6.4 ± 1.7 mL/min/1.73 m2). Patients in both groups ( n = 15) had deficits in height and TBP (mean z-score height-for-age: −1.19 ± 1.05, P < 0.01; mean z-score TBP: −0.71 ± 0.71, P < 0.05). There were no significant differences in weight, height, fat-free mass, TBK and TBP between patients with CRF and ESRF. Conclusions: Linear growth impairment and decreased TBP are common in children with chronic and ESRF. TBK and DEXA may underestimate the degree of malnutrition in these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
10. MEASURING CHANGES IN JUVENILE GRAY SEAL BODY COMPOSITION.
- Author
-
Hall, Ailsa J. and McConnell, Bernie J.
- Subjects
GRAY seal ,HALICHOERUS ,MAMMAL body composition ,BLUBBER ,MARINE mammal anatomy ,BODY weight - Abstract
Determining body composition in gray seals ( Halichoerus grypus) is important when studying their physiology and life history. In this study we investigated the predictability of total body fat (TBF) and protein (TBP) in postweaned gray seal pups from morphometric measurements, blubber thickness using ultrasonographs and bioelectrical impedance analysis (BIA). In postweaned pups, TBF (kg) could be estimated from girth measurements and sex ( n= 45, r
2 = 0.878) using hydrogen isotope dilution methods as the reference. However, TBP could not be reliably estimated from morphometric data. TBF (kg) in yearlings was best predicted from mass ( n= 6, r2 = 0.776) and TBP (kg) from mass/length ( r2 = 0.949). Dorsal blubber thickness using B-mode ultrasound was also a significant predictor of TBF (kg) in postweaned pups ( r2 = 0.725) but BIA was not. Marked pups were recaptured during their first few months of life ( n= 48) and body composition changes investigated. Animals lost mass and TBF after leaving the breeding beach, largely during the first 5–6 mo of life. Postweaned pups were ∼40% TBF and ∼13% TBP whereas yearlings were ∼12% TBF and ∼20% TBP. Pups that survived beyond 6 mo of age then regained mass as protein. Morphometric measurements are a useful field indication of body condition when isotope dilution is impractical. [ABSTRACT FROM AUTHOR]- Published
- 2007
- Full Text
- View/download PDF
11. Use of a reference four-component model to define the effects of insulin treatment on body composition in type 2 diabetes: the ‘Darwin study’.
- Author
-
Packianathan, I. C., Finer, N., Fuller, N. J., Peterson, D. B., Wright, A., and Coward, W. A.
- Subjects
WEIGHT gain ,BODY weight ,INSULIN ,TYPE 2 diabetes ,HYPOGLYCEMIC agents ,DIABETES - Abstract
Aims: To define the effects of insulin treatment on body composition and fat distribution, and investigate the potential role of body weight (BWt) gain predictors in patients with poorly controlled type 2 diabetes. Methods: Assessments of body composition, using a four-component model, and biochemical indices were obtained in 19 patients [mean (SD): age, 60 (8.3) years; BMI, 25.3 (3.3) kg/m
2 ] with poorly controlled type 2 diabetes, despite maximal oral hypoglycaemic agents, receiving insulin [40 (12.2) units/day] at baseline and after 1, 3 and 6 months. Results: Insulin therapy significantly reduced plasma glucose [-6.0 (4.3) mmol/l], improved [HbA1 c [-1.9 (1.8)%], and reversed the BWt lost [3.3 (1.8) kg] before treatment. The 6-month BWt gain [+5.2 (2.7) kg] consisted of body fat [+2.9 (2.7) kg] and fat-free mass [FFM; +2.3 (1.8) kg], with the FFM increase due solely to total body water [TBW; +2.4 (1.5)1], as there were no detectable changes in total body protein or bone mineral, thereby increasing FFM hydration by 1.3%. More body fat was deposited centrally in patients receiving insulin alone than those receiving insulin with an oral hypoglycaemic agent (metformin). Daily insulin dose, HbA1 c and hip circumference were independent predictors of BWt gain. Conclusions: Insulin treatment increased fat and FFM similarly in poorly controlled type 2 diabetes patients, with the FFM gain due entirely to TBW. The possible role of metformin in reducing central fat accumulation following insulin treatment warrants further investigation into its mechanism and potential long-term benefits. [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF
12. Body composition changes following laparoscopic gastric banding for morbid obesity.
- Author
-
Strauss, B. J. G., Marks, S. J., Growcott, J. P., Stroud, D. B., Lo, C. S., Dixon, J. B., and O'Brien, P. E.
- Subjects
- *
BARIATRIC surgery , *LAPAROSCOPIC surgery , *HUMAN body composition , *ANTHROPOMETRY , *NITROGEN in the body , *POTASSIUM in the body , *FAT - Abstract
Most reports of outcome following obesity surgery report weight and co-morbidity changes only. We studied body composition changes in 17 adult patients (15 F, 2 M, age 43±2 years, range 28–58 years), with morbid obesity (initial BMI 40.4±4.9 kg/m2, range 34.7–48.8) who were managed surgically by laparoscopically inserting an adjustable gastric band. Body composition was studied before and after surgery (mean interval of 909±51 days, range 441–1,155 days) using anthropometry (abdominal circumference, AC, sum of four skinfold thicknesses, SFSUM), whole-body potassium counting (TBK), in vivo neutron activation analysis total body nitrogen (TBProtein) and whole-body dual-energy ray absorptiometry (total body percent fat TBF%, and total body bone mineral density TBBMD). Weight loss over the study period was 23.4±2.5 kg. (p<0.0003) with an AC reduction of 20.0±4.5 cm (p<0.008). Both SFSUM and TBF% were significantly reduced (p<0.02 and p<0.0005 respectively). Both TBK and TBProtein after normalization for sex and height, were significantly (p<0.0054 and p<0.001 respectively) reduced, but the ratio of loss of fat mass to fat-free mass, at 4.4:1 was usual for weight loss, and there was no significant changes in the ratio of potassium to protein. TBBMD, after normalization relative to a young same sex adult, was not significantly changed. In this group of patients, most of the substantial weight loss over a 2- to 3-year period was due to loss of fat mass, with relatively less reduction in the components of fat-free mass. Adjustable laparoscopic gastric banding induces fat loss without significant other deleterious effects on body composition. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
13. Chapter 1 : Human body composition and muscle mass
- Author
-
Duda, Krzysztof, Majerczak, Joanna, Nieckarz, Zenon, Heymsfield, Steven B., and Zoladz, Jerzy A.
- Subjects
total body protein ,total body mineral ,total body fat ,basal metabolic rate ,skeletal muscle mass ,total body water - Abstract
Knowledge on body composition is important both in health and in disease, especially when considering chronic (i.e., growing, ageing, pregnancy) and interventional (nutrition, exercise, physical training) biological processes, as well as in predicting, preventing and managing such modern chronic diseases as sarcopenia, obesity, type 2 diabetes or metabolic syndrome. Therefore, in this chapter we present human body composition by taking advantage of widely accepted models, from the simplest 2-compartment model, which allows fat and fat-free body mass to be distinguished, up to a more complex, 6-compartment model, capable of distinguishing body fat, total body water, bone minerals, proteins, soft-tissue minerals, and glycogen. Moreover, in this chapter we provide equations that can be applied in laboratory and clinical practice to predict the main components of body composition, such as body water, skeletal muscles (SMs), body fat, and bone minerals. Special attention is given to the methods of evaluation of SM mass and its importance in health and disease.
- Published
- 2019
14. Protein Synthesis
- Author
-
Kirsch, R. E., Csomós, Géza, editor, and Thaler, Heribert, editor
- Published
- 1983
- Full Text
- View/download PDF
15. Changes in total body nitrogen during weight reduction by very-low-calorie diets.
- Author
-
Morgan, Wynford D., Ryde, Simon J. S., Birks, John L., Thomas, D. Walter, and Kreitzman, Stephen N.
- Subjects
NITROGEN in the body ,WEIGHT loss ,VERY low-calorie diet ,NUCLEAR activation analysis ,BODY mass index ,OBESITY in women ,LEAN body mass - Abstract
Body composition measurements, including total body nitrogen (TBN) by in vivo neutron activation analysis, were made on 11 female volunteers before and after an 11-wk very-low-calorie diet (VLCD) [1695 kJ (405 kcal) 6.7 g N]. Mean body mass index (BMI) changed from 32.1 to 26.2 kg/m², corresponding to a mean weight loss of 16.2 ± 2.4 (SD) kg. The mean loss of TBN was 125 ± 57 g, equivalent to 781 ± 356 g protein. The fat-free mass (FFM) component of the weight loss was calculated by two different methods as 23.5% (±3% SEM) and 22.8% (±2.7% SEM), respectively, thereby demonstrating the improved protein sparing of ketogenic VLCDs. FFM loss was not clearly related to BMI. [ABSTRACT FROM AUTHOR]
- Published
- 1992
- Full Text
- View/download PDF
16. Body composition analysis in the assessment of cancer cachexia treatment outcomes
- Author
-
Aslani, Alireza
- Subjects
Eicosapentaenoic Acid ,Total Body Protein ,Total Body Water ,Total Body Fat ,Cancer cachexia ,Surgery ,Whipple's Procedure ,Pancreatic cancer ,Fish oil ,Body composition ,Nutrition - Abstract
Introduction Cachexia is characterised by a marked weight loss and the presence of anorexia, anaemia, and asthenia. Although cachexia is often associated with the presence and growth of tumour and observed in solid tumours of the upper gastrointestinal tract, its presence is not unique to cancer and is often also present in most chronic, end-stage diseases processes. The loss of body fat, altered lipid metabolism, increase in the resting energy expenditure, and the increased loss of body protein the degree of which is associated with poor survival, are all hallmarks of this detrimental disease. The clinical aspects and consequences of cachexia can simply be summarised as morbidity, debilitating conditions, and mortality. The conditions such as loss of muscle mass, impaired muscle function, fatigue, reduced activity and functional capacity by themselves are enough to severely and significantly affect the patients’ QL. Although different interventional procedures and therapies are available for the treatment of cachexia and its symptoms, effective methods to evaluate their benefits and outcomes have not been tested or investigated. It was, therefore, the aim of this project to use body composition analysis as a clinical tool and evaluate the effectiveness and outcome of interventional and therapeutic procedures in three groups of patients with cancer. Methods Three patient groups were investigated: 1) patients with pancreatic cancer undergoing Whipple’s Procedure, 2) patients with pancreatic cancer undergoing cancer chemotherapy and receiving either EPA or placebo, and 3) patients with malignant mesothelioma undergoing cancer chemotherapy plus thalidomide or thalidomide alone. Body composition analysis techniques were used to assess the changes in TBN, TBF, TBK, and TBW. In addition, the body composition parameters together with clinical measures were also used to determine parameters influencing survival. The malignant mesothelioma patients were randomised into patients who received gemcitabine / cisplatin plus thalidomide and those who received thalidomide alone. The pancreatic cancer patients undergoing chemotherapy were randomised into the group who were receiving EPA and those who were receiving placebo. In addition, these patients were also investigated on the basis of their disease extent where they were separated into two groups of metastatic and locally advanced. Unpaired T-Test and ANOVA were used to determine differences between groups. Kaplan-Meier analysis and Cox’s Regression were used to assess survival in all three patient cohorts. The Whipple’s Procedure patients were separated into those who received a Clear Margin and those who received an Unclear Margin during their resection. Results 1) In the pancreatic cancer patients undergoing Whipple’s Procedure, compared to the base-line, there were highly significant changes in Weight (p=0.006), BMI (p=0.005), and FM (p=0.007) followed by significant changes in %BFat (p=0.016), TBK/Ht (p=0.021), LBM (By TBK) (p=0.023), LBM (Van Loan) (p=0.034), and LBM (Segal) (p=0.038) at the 14 week time-point. At the 26 weeks post-operative time point, the only significant changes were in the FM (p=0.012), %BFat (p=0.003), and BMI (p=0.027) parameters. There was also a deviation between the two groups in their TBN, LBM and TBW content observable in a long-term setting and fat content in the relatively shorter-term. Although the Unclear Margin group had lower body composition values, both groups seem to begin to gradually “equalise” around the 14 weeks post-operative time-point. The survival analysis results for the Whipple’s Procedure patients demonstrated that Margin Status (p=0.001), Fat Mass (p=0.003) and Age (p=0.081) were significant and could influence survival. 2) When the second cohort pancreatic cancer patients undergoing chemotherapy were analysed, they were initially separated according to the extent of their disease The results of the analyses of body composition changes between measurement time-points for the each group separately, suggested that the patients with locally advanced disease maintain their Weight, FM, and TBN but are more likely to have a lower TBW by the end of the four month of chemotherapy. However, the patients with metastatic pancreatic cancer maintain their TBW but are more likely to have a decreased fat compartment and a higher FFM. The QL analysis showed that the metastatic group are performing “worse” than the locally advanced group especially in term of their Dyspnoea, Nausea & Vomiting, and Sexuality. In addition, the Karnofsky score showed that the metastatic group are not performing as well as the locally advanced group. Furthermore, for the metastatic group there was an increase in the patients’ pain with a decline in mood and general performance as well as increase in gastrointestinal symptoms. Pain Card scores also showed a general increase for the metastatic group and a general decrease for the locally advanced group. When the pancreatic cancer patients undergoing chemotherapy were separated according to whether they received EPA or placebo, the results demonstrated that firstly, due to the fact that the patients were well randomised, the two groups commenced the trial with similar and statistically non-significantly different body composition parameters. Secondly, the two groups were also found to be statistically not different at their corresponding measurement time-points. And thirdly, the patients receiving placebo compared to those receiving EPA lost more Weight, and FM but less TBW throughout the trial. The TBK/Ht (p=0.044), TBK (p=0.042), and LBM (By TBK) (p=0.042), however, showed statistically significant differences where in all three parameters the EPA showed an increase compared to the base-line (pre-chemotherapy). Results of the survival analysis demonstrated that the use of EPA in this group of pancreatic cancer patients did not provide any benefit. In fact, as it was shown in the Kaplan-Meier plot, the group of patients receiving the EPA had a “worse” survival than the group receiving the placebo. The QL results showed that placebo group improved in their functional scales, but increased their Altered Bowel Habit scores with an increase in the perception of pain and decrease in relief from pain. The EPA group, however, showed a decrease in the Loss of Appetite, Dyspnoea, Pain, Pancreatic Pain, and Fatigue, and improvements in Role Functioning and Sexuality. 3) Results of the malignant mesothelioma patients demonstrated that both study arms show similar weight changes. In addition, body composition measurements indicated that the gemcitabine / cisplatin chemotherapy plus thalidomide group had a greater TBN loss and a greater TBW gain than the thalidomide-alone group. This loss of TBN and gain in TBW looked to be “concealed” in the weight. The results of the survival analysis carried out on the mesothelioma patient group suggested that haemoglobin levels (p=0.001), Age (p=0.007), and NI (p=0.008) are the parameters that can influence the survival of patients with malignant mesothelioma undergoing chemotherapy. Conclusions 1) The trend in body composition changes in the Whipple’s Procedure group showed that, although both groups may start with non-significantly different body composition, they tended to grow closer around the 14 week point indicating that the Clear Margin group may lose more than Unclear Margin group. The implications of these findings, therefore, were that once the most appropriate surgical procedure is performed, an adjuvant therapy regimen (such as chemotherapy) at around 14 weeks may have the most impact on the patient’s overall treatment outcome. 2) When the pancreatic cancer patients were separated by the extent of their disease, the results lead to the conclusion that the patients with locally advanced disease maintain their Weight, FM, and TBN but are more likely to have a lower TBW by the end of the four month of chemotherapy. However, the patients with metastatic pancreatic cancer maintain their TBW but are more likely to have a decreased fat compartment and a higher FFM. The QL analysis concluded that the results may point to a worsening and/or progressing disease which is consistent with classic metastatic disease aetiology. From the results of the pancreatic cancer patients undergoing cancer chemotherapy it was concluded that the use of EPA in this group of pancreatic cancer patients undergoing cancer chemotherapy with gemcitabine results in a non-significant reduction in weight loss, FM loss, and TBW gain with a statistically significant increase in FFM. The results of the survival analysis was, however, contradictory suggesting that patients receiving EPA may have a worse survival than the placebo group. The QL analysis here concluded that that EPA does improve the QL of this group of pancreatic cancer patients. 3) From the malignant mesothelioma group it was concluded that provided that the overall anti-cancer potential of gemcitabine / cisplatin plus thalidomide is comparable with that of thalidomide-alone, then by looking purely from the body composition angle one may be able to suggest the use of thalidomide alone in the treatment of malignant mesothelioma in this group of patients. From the results of the survival analysis, the fact that the Study Arm parameter did not reach statistical significance could indicate that survival in these patients is not affected by the presence or absence of chemotherapy with gemcitabine and cisplatin. The body composition techniques were used here as a tool to monitor changes in various body composition parameters to assess the outcomes, including survival, of the administration of different therapies and interventional procedures in these three groups of cancer patients. For these purposes, these techniques were demonstrated to be an effective and invaluable tool.
- Published
- 2008
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.